Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Panbela Therapeutics, Inc. | ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Panbela Therapeutics, Inc. | ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Panbela Therapeutics, Inc. | ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Panbela Therapeutics, Inc. | ex31-1.htm |
| EX-21.1 - EXHIBIT 21.1 - Panbela Therapeutics, Inc. | ex21-1.htm |
| EX-10.7 - EXHIBIT 10.7 - Panbela Therapeutics, Inc. | ex10-7.htm |
| 10-K - FORM 10-K - Panbela Therapeutics, Inc. | snbp20161231_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in Registration Statement No. 333-213687 on Form S-1 and Registration Statement No.333-213610 on Form S-8 of our report dated March 30, 2017 included in this Annual Report on Form 10-K of Sun BioPharma, Inc. (the “Company”), relating to the consolidated financial statements of the Company as of December 31, 2016 and 2015 and for the years then ended.
|
|
| |
|
/s/ Cherry Bekaert |
|
|
|
Tampa, Florida |
| |
|
March 30, 2017 |
||